DexCom, Inc. (DXCM)

NASDAQ: DXCM · Real-Time Price · USD
75.78
-0.66 (-0.86%)
At close: Sep 18, 2025, 4:00 PM EDT
75.72
-0.06 (-0.08%)
After-hours: Sep 18, 2025, 4:24 PM EDT
-0.86%
Market Cap29.72B
Revenue (ttm)4.30B
Net Income (ttm)571.50M
Shares Out 392.16M
EPS (ttm)1.43
PE Ratio52.99
Forward PE32.13
Dividendn/a
Ex-Dividend Daten/a
Volume9,223,144
Open72.93
Previous Close76.44
Day's Range71.80 - 75.96
52-Week Range57.52 - 93.25
Beta1.49
AnalystsStrong Buy
Price Target99.89 (+31.82%)
Earnings DateOct 23, 2025

About DXCM

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time... [Read more]

Sector Healthcare
IPO Date Apr 14, 2005
Employees 10,300
Stock Exchange NASDAQ
Ticker Symbol DXCM
Full Company Profile

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial Statements

Analyst Summary

According to 19 analysts, the average rating for DXCM stock is "Strong Buy." The 12-month stock price target is $99.89, which is an increase of 31.82% from the latest price.

Price Target
$99.89
(31.82% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. DXCM, citing that the company sold the "adulterated" device.

5 hours ago - Benzinga

Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025

VIENNA--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose ...

3 days ago - Business Wire

DexCom, Inc. (DXCM) Presents At Baird Global Healthcare Conference 2025 Transcript

DexCom, Inc. (NASDAQ:DXCM) Baird Global Healthcare Conference 2025 September 10, 2025 2:00 PM EDT Company Participants Sean Christensen - Vice President of Finance and Investor Relations Conference C...

8 days ago - Seeking Alpha

Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day

SAN DIEGO & BURNABY, British Columbia--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of its first open call in the U.S. and Canada i...

8 days ago - Business Wire

DexCom, Inc. (DXCM) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

DexCom, Inc. (NASDAQ:DXCM) 2025 Wells Fargo Healthcare Conference September 3, 2025 2:15 PM EDT Company Participants Jacob Leach - President & COO Jereme Sylvain - Executive VP, CFO & Chief Accountin...

14 days ago - Seeking Alpha

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Wall Street gives these three diverse names Strong Buy recommendations with high potential upside.

Other symbols: GESLB
21 days ago - Kiplinger

Dexcom Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: The 2025 Wells Fargo Health...

23 days ago - Business Wire

Dexcom's Arizona facility can service good portion of U.S. business, says CEO

CNBC's "The Exchange" team discusses the potential of tariffs on pharmaceuticals, U.S. manufacturing and more with Dexcom CEO and chairman Kevin Sayer.

6 weeks ago - CNBC Television

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

All but two of the S&P 500's sectors are up so far in 2025.

Other symbols: BSXCAHEWISRGLLYPODDSYK
7 weeks ago - Market Watch

DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript

DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Jacob Steven Leach - President & COO Jereme M. Sylvain - Executive VP, CFO & Chief Accounting...

7 weeks ago - Seeking Alpha

Dexcom beats estimates for quarterly results, names new CEO

Dexcom beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.

7 weeks ago - Reuters

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan.

7 weeks ago - Business Wire

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continu...

7 weeks ago - Business Wire

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter gluc...

7 weeks ago - Business Wire

Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration

PORTSMOUTH, N.H.--(BUSINESS WIRE)-- #care--Tenovi, a leading provider of remote patient monitoring (RPM) solutions, today announced it now supports Dexcom continuous glucose monitoring (CGM) data dire...

2 months ago - Business Wire

DexCom: Delivering Consistent Growth

DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Q1 results showed 13% revenue growth, beating expectations, though earnings were slightly below...

2 months ago - Seeking Alpha

15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

Growth stocks can be expensive, but if you are trying to be aggressive with a portion of your investment portfolio, you often have to pay a premium for the privilege.

2 months ago - Market Watch

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company's one-of-a-kind NIL (Name, Im...

2 months ago - Business Wire

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (...

2 months ago - GlobeNewsWire

The Best Growth Stocks to Buy

Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.

2 months ago - Kiplinger

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Management wil...

2 months ago - Business Wire

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th S...

3 months ago - Business Wire

Jefferies' high conviction US stocks for the summer: Nvidia among top picks

Global brokerage firm Jefferies shared their top 28 US stocks in the “highest-conviction Buy rated” stocks. Jefferies shared the list as the US market is coming fresh off its best month in May since N...

Other symbols: COFNVDA
3 months ago - Invezz

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO

SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO.

4 months ago - Business Wire

DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins, leading me to lower my rating from buy to hold. Despite demographic tailwinds and a growing market, gr...

4 months ago - Seeking Alpha